[ad_1]
An experimental vaccine, developed by scientists more than 40 years ago, showed an immune response to humans and was successful in protecting monkeys from infection, according to a study published in the Lancet medical journal. The vaccine will be tested in the next phase of the trial, after the drug has been proven harmless to humans. It will be tested on 2,600 women in South Africa to determine if it will succeed in preventing AIDS. Despite the encouraging results achieved so far, this does not guarantee the success of the Qar in the next experimental phase called "HTNV705" or "Imbukudu", meaning rock in Zulu.
Dan Barroch, the study supervisor and professor at Harvard University, told AFP: "While the data is encouraging, we need to be more cautious, successful of the vaccine by protecting two-thirds of the monkeys in a laboratory experiment does not mean that it will protect humans, so we must wait for the results of the study before knowing if this will protect humans from AIDS., The fifth vaccine to test its efficacy in humans over the 35-year history of AIDS in the world. "
A single vaccine, called RV444 (RV144), has a form of disease prevention. RIV 144 was announced in 2009 to reduce the risk of HIV infection by 31.2% among 16,000 Thai volunteers, but was insufficient to clbadify it as an antiviral drug.
The study used vaccine formulations called "mosaic vaccines". (19659002) Tests also showed that the vaccine was safe, but five participants reported some side effects, such as stomach pain, diarrhea and dizziness. Or back pain.
In a separate study, the drug itself is a complete prevention of AIDS in two-thirds of the 72 monkey monkeys to which six doses of pseudo-HIV virus
Franco Venter from the University of Utwatersrand and the South African AIDS Institute have urged scientists to "At this point, when we have developed promising vaccines that have not developed, this drug is new in many ways, so it's a good thing. is an exciting vaccine, but we still have a long way to go. "
AIDS pandemic by 37 million people. Nearly 1.8 million people die from the disease and about one million die each year.
Estimates of 80 million people have been diagnosed with HIV since the diagnosis of the disease for the first time in the early 1980s and about 35% have died in the world so far. No drug has proven effective because the HIV virus develops easily and can only hide in cells and escape the immune system to reappear and spread again after years. AIDS patients are currently relying on treatments to prevent the virus from staying healthy.
The results of the latest study come at a time when the International AIDS Conference will be held in Amsterdam from 23 July to 27 July. 19659002] Source: BBC
[ad_2]
Source link
